CONTINUE TO SITE

OR WAIT null SECS

Spotlight

RSNA 2021 Coverage CT Image IQ Quiz

RSNA 2021 CoverageCTImage IQ Quiz

Topics

View More MRI CT Ultrasound Mammography X-Ray Facility Management AI View More

MRICTUltrasoundMammographyX-RayFacility ManagementAIView More

News

All News Blogs

Media

Around the Practice Between the Lines Image IQ Medical World News Podcasts Videos

Around the Practice Between the LinesImage IQMedical World NewsPodcastsVideos

Conferences

Conference Coverage Conference Listing

DI Executive

Resources

CME/CE E-books Education Partners Sponsored

CME/CEE-booksEducationPartnersSponsored

Subscribe

eNewsletter

Advertise
Contact Us
Editorial
Editorial Board
Do Not Sell My Personal Information
Privacy
Terms and Conditions

Spotlight

RSNA 2021 Coverage
CT
Image IQ Quiz

TopicsSee All >

MRI
CT
Ultrasound
Mammography
X-Ray
Facility Management
AI
View More

Advertise
Contact Us
Editorial
Editorial Board
Do Not Sell My Personal Information
Privacy
Terms and Conditions

Between the Lines

18F-Fluciclovine Versus 68Ga-PSMA-11 Imaging for Prostate Cancer Biochemical Recurrence

December 23rd 2021

Steven Finkelstein, MD, DABR, FACRO, and Louis J. Mazzarelli, MD, react to the article, “A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT,” by Pernthaler B, et al.